BR9815775A - Anticorpos monoclonais anti-antìgeno carcinoembriÈnico (cea) humanizados de elevada afinidade - Google Patents
Anticorpos monoclonais anti-antìgeno carcinoembriÈnico (cea) humanizados de elevada afinidadeInfo
- Publication number
- BR9815775A BR9815775A BR9815775-2A BR9815775A BR9815775A BR 9815775 A BR9815775 A BR 9815775A BR 9815775 A BR9815775 A BR 9815775A BR 9815775 A BR9815775 A BR 9815775A
- Authority
- BR
- Brazil
- Prior art keywords
- cea
- high affinity
- monoclonal antibodies
- carcinoembryonic
- humanized
- Prior art date
Links
- 102000012406 Carcinoembryonic Antigen Human genes 0.000 abstract 5
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 abstract 5
- 206010028980 Neoplasm Diseases 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000011503 in vivo imaging Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Patente de Invenção: <B>''ANTICORPOS MONOCLONAIS ANTI-ANTìGENO CARCINOEMBRIÈNICO (CEA) HUMANIZADOS DE ELEVADA AFINIDADE''<D>. Novos anticorpos monoclonais humanizados, fragmentos ou derivados destes que especificamente ligam antígeno carcinoembriónico (CEA) são fornecidos, bem como métodos para sua preparação. Estes anticorpos humanizados são úteis no tratamento de cânceres que expressam CEA, bem como para os propósitos de diagnóstico, por exemplo, imagem in vivo de tumores ou células cancerígenas que expressam CEA.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR9815775-2A BR9815775A (pt) | 1998-02-25 | 1998-02-25 | Anticorpos monoclonais anti-antìgeno carcinoembriÈnico (cea) humanizados de elevada afinidade |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR9815775-2A BR9815775A (pt) | 1998-02-25 | 1998-02-25 | Anticorpos monoclonais anti-antìgeno carcinoembriÈnico (cea) humanizados de elevada afinidade |
| PCT/US1998/003680 WO1999043817A1 (en) | 1998-02-25 | 1998-02-25 | High affinity humanized anti-cea monoclonal antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9815775A true BR9815775A (pt) | 2000-11-21 |
Family
ID=25665184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9815775-2A BR9815775A (pt) | 1998-02-25 | 1998-02-25 | Anticorpos monoclonais anti-antìgeno carcinoembriÈnico (cea) humanizados de elevada afinidade |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BR9815775A (pt) |
-
1998
- 1998-02-25 BR BR9815775-2A patent/BR9815775A/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03000527A (es) | Composiciones y metodos para la terapia y diagnostico de cancer ovarico. | |
| NZ512247A (en) | Compositions and methods for therapy and diagnosis of ovarian cancer | |
| HUP9901562A2 (hu) | Anti-CEA monoklonális antitestek, az ezeket tartalmazó konjugátumok és ezek felhasználása antitest irányított enzimes előgyógyszer terápiában | |
| DE69734109D1 (de) | Humanisierung von anti-carcinoembryonalen Antigen anti-idiotypischen Antikörper und dessen Verwendung als Tumorvakzin und zur Markierung | |
| WO1999004265A8 (en) | Cancer associated nucleic acids and polypeptides | |
| CY1113326T1 (el) | Ανθρωπινα αντισωματα τα οποια δεσμευουν ανθρωπινη il-12 και μεθοδοι παραγωγης τους | |
| EA200501206A1 (ru) | Производные от сурвивина пептиды и их применение | |
| ATE229073T1 (de) | Protein e25a, methoden zu dessen herstellung und anwendung | |
| WO2005055936A3 (en) | Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells | |
| BRPI0414513A (pt) | kid3 e anticorpos de kid3 que se ligam a ele | |
| AU2829889A (en) | Sf-25 colon adenocarcinoma antigen, and antibodies which recognize this antigen | |
| WO2003064593A3 (en) | Antigen panels and methods of using the same | |
| ATE248189T1 (de) | Antikörper gegen vasp (vasodilator-stimulated phosphoprotein), hybridomzellen für deren gewinnung, und deren verwendung | |
| DK0566571T3 (da) | Diagnose af metastatisk cancer ved hjælp af mts-1-genet | |
| NO20004250D0 (no) | Humaniserte anti-TAG-72 monoklonale antistoffer med høy affinitet | |
| NO20004251L (no) | Humaniserte anti-CEA monoklonale antistoffer med høy affinitet | |
| EA200601405A1 (ru) | Гуманизированное антитело | |
| BR9815775A (pt) | Anticorpos monoclonais anti-antìgeno carcinoembriÈnico (cea) humanizados de elevada afinidade | |
| WO2004094612A3 (en) | Cancer specific monoclonal antibodies | |
| WO2004101762A3 (en) | Detection and treatment of cancers of the colon | |
| WO2003024302A3 (en) | Detection and treatment of cancers of breast | |
| ATE475710T1 (de) | Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs | |
| BR9815776A (pt) | Anticorpos monoclonais anti-tag-72 humanizados com alta afinidade | |
| WO2003024304A3 (en) | Detection and treatment of cancers of the liver | |
| AU2002326318A1 (en) | Targeting tumor cell antigens: antibodies useful for the diagnosis, prognosis, and treatment of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 7,8 E 9A ANUIDADES |
|
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007. |
|
| B15K | Others concerning applications: alteration of classification |
Ipc: C07K 16/30 (2006.01), C07K 16/46 (2006.01), C12N 1 |